Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis
- PMID: 36990505
- PMCID: PMC10053756
- DOI: 10.1136/bmj-2022-072003
Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis
Abstract
Objective: To determine the relative efficacy of structured named diet and health behaviour programmes (dietary programmes) for prevention of mortality and major cardiovascular events in patients at increased risk of cardiovascular disease.
Design: Systematic review and network meta-analysis of randomised controlled trials.
Data sources: AMED (Allied and Complementary Medicine Database), CENTRAL (Cochrane Central Register of Controlled Trials), Embase, Medline, CINAHL (Cumulative Index to Nursing and Allied Health Literature), and ClinicalTrials.gov were searched up to September 2021.
Study selection: Randomised trials of patients at increased risk of cardiovascular disease that compared dietary programmes with minimal intervention (eg, healthy diet brochure) or alternative programmes with at least nine months of follow-up and reporting on mortality or major cardiovascular events (such as stroke or non-fatal myocardial infarction). In addition to dietary intervention, dietary programmes could also include exercise, behavioural support, and other secondary interventions such as drug treatment.
Outcomes and measures: All cause mortality, cardiovascular mortality, and individual cardiovascular events (stroke, non-fatal myocardial infarction, and unplanned cardiovascular interventions).
Review methods: Pairs of reviewers independently extracted data and assessed risk of bias. A random effects network meta-analysis was performed using a frequentist approach and grading of recommendations assessment, development and evaluation (GRADE) methods to determine the certainty of evidence for each outcome.
Results: 40 eligible trials were identified with 35 548 participants across seven named dietary programmes (low fat, 18 studies; Mediterranean, 12; very low fat, 6; modified fat, 4; combined low fat and low sodium, 3; Ornish, 3; Pritikin, 1). At last reported follow-up, based on moderate certainty evidence, Mediterranean dietary programmes proved superior to minimal intervention for the prevention of all cause mortality (odds ratio 0.72, 95% confidence interval 0.56 to 0.92; patients at intermediate risk: risk difference 17 fewer per 1000 followed over five years), cardiovascular mortality (0.55, 0.39 to 0.78; 13 fewer per 1000), stroke (0.65, 0.46 to 0.93; 7 fewer per 1000), and non-fatal myocardial infarction (0.48, 0.36 to 0.65; 17 fewer per 1000). Based on moderate certainty evidence, low fat programmes proved superior to minimal intervention for prevention of all cause mortality (0.84, 0.74 to 0.95; 9 fewer per 1000) and non-fatal myocardial infarction (0.77, 0.61 to 0.96; 7 fewer per 1000). The absolute effects for both dietary programmes were more pronounced for patients at high risk. There were no convincing differences between Mediterranean and low fat programmes for mortality or non-fatal myocardial infarction. The five remaining dietary programmes generally had little or no benefit compared with minimal intervention typically based on low to moderate certainty evidence.
Conclusions: Moderate certainty evidence shows that programmes promoting Mediterranean and low fat diets, with or without physical activity or other interventions, reduce all cause mortality and non-fatal myocardial infarction in patients with increased cardiovascular risk. Mediterranean programmes are also likely to reduce stroke risk. Generally, other named dietary programmes were not superior to minimal intervention.
Systematic review registration: PROSPERO CRD42016047939.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from Dalhousie University for the submitted work; no other relationships or activities that could appear to have influenced the submitted work. BCJ received a grant from Texas A&M AgriLife Research to fund investigator initiated research related to saturated and polyunsaturated fats. The grant was from Texas A&M AgriLife institutional funds from interest and investment earnings, not a sponsoring organisation, industry, or company.
Figures
Comment in
-
In adults at CV risk, Mediterranean-style or low-fat dietary programs vs. minimal interventions reduce all-cause mortality.Ann Intern Med. 2023 Jul;176(7):JC78. doi: 10.7326/J23-0043. Epub 2023 Jul 4. Ann Intern Med. 2023. PMID: 37399556
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials.BMJ. 2020 Apr 1;369:m696. doi: 10.1136/bmj.m696. BMJ. 2020. PMID: 32238384 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article. Review.
-
PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.BMJ. 2022 May 4;377:e069116. doi: 10.1136/bmj-2021-069116. BMJ. 2022. PMID: 35508321
-
Reduction in saturated fat intake for cardiovascular disease.Cochrane Database Syst Rev. 2015 Jun 10;(6):CD011737. doi: 10.1002/14651858.CD011737. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2020 May 19;5:CD011737. doi: 10.1002/14651858.CD011737.pub2. PMID: 26068959 Updated. Review.
Cited by
-
Sex-specific dietary habits and their association with weight change in healthy adults.BMC Med. 2024 Nov 6;22(1):512. doi: 10.1186/s12916-024-03730-3. BMC Med. 2024. PMID: 39501340 Free PMC article.
-
A Saudi Heart Association Position Statement on Obesity and Cardiovascular Disease.J Saudi Heart Assoc. 2024 Oct 2;36(3):263-300. doi: 10.37616/2212-5043.1391. eCollection 2024. J Saudi Heart Assoc. 2024. PMID: 39469000 Free PMC article.
-
Comparative effects of behaviour change techniques using eHealth and mHealth in promoting dietary behaviour: protocol for a systematic review and component network meta-analysis.BMJ Open. 2024 Oct 15;14(10):e084774. doi: 10.1136/bmjopen-2024-084774. BMJ Open. 2024. PMID: 39414285 Free PMC article.
-
Impact of a Mediterranean-Inspired Diet on Cardiovascular Disease Risk Factors: A Randomized Clinical Trial.Nutrients. 2024 Jul 26;16(15):2443. doi: 10.3390/nu16152443. Nutrients. 2024. PMID: 39125324 Free PMC article. Clinical Trial.
-
Adherence to a Healthy Diet and Risk of Multiple Carotid Atherosclerosis Subtypes: Insights from the China MJ Health Check-Up Cohort.Nutrients. 2024 Jul 19;16(14):2338. doi: 10.3390/nu16142338. Nutrients. 2024. PMID: 39064782 Free PMC article.
References
-
- Sacks FM, McManus K. Cardiovascular disease and lifestyle modification. In: Cardiovascular Therapeutics: A Companion to Braunwald’s Heart Disease. Elsevier, 2013: 442-53 10.1016/B978-1-4557-0101-8.00026-6. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical